NanoFuse Biologics appoints new CEO as Dr. Kingsley Chin steps down

Spinal Tech

NanoFUSE Biologics on March 16 appointed Jake Lubinski as CEO.

He was also named president of commercialization of parent company KICVentures.

Previously, Mr. Lubinski served as president of NanoFUSE and president of commercialization and acquisition of KICVentures. 

He succeeds Kingsley Chin, MD, who stepping down to focus on expanding KICVentures' healthcare portfolio.

Since 2010, Mr. Lubinski served in several executive leadership roles within KICVentures portfolio companies, spearheading operational, business development and growth and acquisition initiatives.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Podcast

Featured Whitepapers